Related Experiment Video
Updated: Jun 3, 2026
Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
Intravenous ascorbic acid (vitamin C) administration in myomectomy: a prospective, randomized, clinical trial
Elham Pourmatroud1, Leila Hormozi, Masoud Hemadi
1Obstetrics and Gynecology Department, Emam Khomeini Hospital, Ahwaz Jundishapur University of Medical Science (AJUMS), Azadegan Street, Ahvaz, Iran. e.pourmatroud@yahoo.com
Background:
To assess the usefulness of using ascorbic acid (vitamin C) administration in abdominal myomectomy.
Materials And Methods:
A total of 102 patients were divided two groups in this prospective, clinical trial. Group A had received 2 g of ascorbic acid during a myomectomy, and group B had a myomectomy without any interventions. The operative time, blood loss, days of hospitalization, post-operative complications and rate of blood transfusions were compared between the two groups.
Results:
The blood loss (521.44 ± 199.24 vs. 932.9 ± 264.38 ml; p value <0.001), duration of the operation time (42 ± 13.9 vs. 68 ± 21.7 min; p value <0.001), days of hospitalization (2.7 ± 0.69 vs. 3.1 ± 0.59 days; p value 0.002) in group A were significantly less than in group B (p value 0.001). The chance risk ratio of a blood transfusion in group A was 0.4 (7.7 vs. 18% 95% CI of 0.1-1; p value 0.07). There was a significant correlation between the volume of bleeding and post-operative complications in both groups (p value in group A = 0.03; in group B = 0.004).
Conclusion:
The administration of ascorbic acid (vitamin C) in abdominal myomectomy could reduce the blood loss during the procedure, operation time and days of hospitalization.
